
Blood purification in sepsis and systemic inflammation
Author(s) -
Ying Feng,
Jin-Yu Peng,
Zhiyong Peng
Publication year - 2021
Publication title -
current opinion in critical care, with evaluated medline/current opinion in critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.212
H-Index - 88
eISSN - 1080-8183
pISSN - 1070-5295
DOI - 10.1097/mcc.0000000000000890
Subject(s) - sepsis , medicine , septic shock , cytokine storm , intensive care medicine , shock (circulatory) , cytokine , inflammation , clinical trial , systemic inflammation , immunology , disease , covid-19 , infectious disease (medical specialty)
Sepsis and septic shock are life-threatening diseases with high mortality. Although efforts have made to improve the survivals, the outcomes are still frustrating. Blood purification was thought to be a promising adjunctive therapy to regulate the excessive cytokine storm or to reduce the endotoxin activity caused by sepsis. Critically ill COVID-19 characterized with the similar disease to sepsis may also benefit from blood purification.